Quetiapine and Wolff-Parkinson-White Syndrome
Quetiapine is occasionally associated with cardiovascular adverse effects such as QTc prolongation. QTc prolongation is a side effect that requires monitoring in order to avoid more serious cardiac complications. One particular understudied area is the potential for antipsychotics to elicit electroc...
Saved in:
Main Authors: | Michael Chen, Hassaan Gomaa, Alonso Cortez-Resendiz, Christopher Martin, Andrew Francis, Alfredo Bellon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Psychiatry |
Online Access: | http://dx.doi.org/10.1155/2020/6633385 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Wolff-Parkinson-White Syndrome Mimics a Conduction Disease
by: S. Marrakchi, et al.
Published: (2014-01-01) -
Multiple Cardiac Rhabdomyomas, Wolff-Parkinson-White Syndrome, and Tuberous Sclerosis: An Infrequent Combination
by: Elena Castilla Cabanes, et al.
Published: (2014-01-01) -
Sudden Cardiac Death: The Most Feared but Potentially Preventable Presentation of Wolff-Parkinson-White Syndrome
by: Ana Rita Pereira, et al.
Published: (2021-01-01) -
Hypertrophic Cardiomyopathy and Wolff-Parkinson-White Syndrome in a Young African Soldier with Recurrent Syncope
by: Mohammed Abdullahi Talle, et al.
Published: (2019-01-01) -
Progression of Wolff–Parkinson–White pattern 12-lead electrocardiogram changes in an asymptomatic athlete
by: Hwei Sian Shauna Sim, et al.
Published: (2023-07-01)